Vince Associates Clinical Research, Inc.

Overland Park, Kansas 66212

0 studies enrolling now · 19 studies all time

What they study most

Advanced Malignancies, Alzheimer's Disease, Anti-Hepatitis A Antibody Levels in Heathy Subjects, Clostridium Difficile, Clostridium Difficile Associated Disease, Cocaine Abuse, Epilepsy, Gout, Healthy Subjects, Healthy Volunteer, Healthy Volunteers, Hypercholesterolemia

Studies at this site

• A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users — Completed
• Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients — Completed
• A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years — Completed
• Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147 — Completed
• A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects — Completed
• A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects — Completed
• Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes — Completed
• A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users — Completed
• Anti-Hepatitis A Virus, Pharmacokinetics, and Safety of Immune Globulin (Human) — Completed
• Pharmacokinetics And Relative Bioavailability Of Bococizumab (PF-04950615; RN316) When Administered To The Abdomen, Thigh Or Upper Arm — Completed
• Study for Naltrexone on the Abuse Potential of Methylphenidate — Completed
• A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine. — Completed
• A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers — Completed
• CSD170501: Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette — Completed
• Study to Assess Potential Interactions Between Intravenous Cocaine and Oral Lorcaserin — Completed
• Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. — Completed
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira) In Healthy Subjects (REFLECTIONS B538-07)) — Completed
• Safety Study of Two Oral Formulations of MGCD265 Administered in Healthy Subjects in the Fasting State — Completed
• A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets — Status unconfirmed